Creating a genetic risk score for coronary artery disease

Current Atherosclerosis Reports

Volumn 11, Issue 3, 2009, Pages 175-181

  Dandona, Sonny ^a   Roberts, Robert ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; BLOOD CLOTTING FACTOR 5; LEUKOTRIENE A4 HYDROLASE; LIPOPROTEIN; LYMPHOTOXIN; MYOCYTE ENHANCER FACTOR 2; OX40 LIGAND; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ATHEROSCLEROTIC PLAQUE; CHROMOSOME 9P; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; MONOGENIC DISORDER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN THROMBOSIS;

CHROMOSOME MAPPING; CORONARY ARTERY DISEASE; GENOTYPE; HUMANS; PHENOTYPE; RISK FACTORS;

EID: 65449116040     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-009-0028-4     Document Type: Review

References (42)

1. Cutler D, McClelland M: Economic benefits of heart attack treatments outweigh the cost. Available at http://www.nber.org/disget/oct98/ w6514html 2007. Accessed December 15, 2007.
2. Brown MS, Goldstein JL: FDmilial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci U S A 1974, 71: 788-792.
3. Boren J, Ekstrom U, Agren B, et al.: The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem 2001, 276: 9214-9218.
4. Soutar AK, Naoumova RP: Autosomal recessive hypercholesterolemia. Semin Vasc Med 2004, 4: 241-248.
5. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 354: 1264-1272.
6. Schutz F, Mevissen V, Krantz C, et al.: Robust association of the APOE epsilon4 allele with premature myocardial infarction especially in patients without hypercholesterolaemia: The Aachen study. Eur J Clin Invest 2007, 37: 106-108
7. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al.: Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008, 359: 1897-1908.
8. Horne BD, Camp NJ, Anderson JL, et al.: Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J Am Coll Cardiol 2007, 49: 2053-2060.
9. Kyriakou T, Pontefract DE, Viturro E, et al.: Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Hum Mol Genet 2007, 16: 1412-1422.
10. Chan L, Boerwinkle E: Gene-environment interactions and gene therapy in atherosclerosis. Cardiol Rev 1994, 2: 130-137.
11. Helgadottir A, Manolescu A, Helgason A, et al.: A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006, 38: 68-74.
12. Assimes TL, Knowles JW, Priest JR, et al.: Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet 2008, 123: 399-408.
13. Ozaki K, Ohnishi Y, Iida A, et al.: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002, 32: 650-654.
14. Clarke R, Xu P, Bennett D, et al.: Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet 2006, 2: E107.
15. Wang X, Ria M, Kelmenson PM, et al.: Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 2005, 37: 365-372.
16. Koch W, Hoppmann P, Mueller JC, et al.: Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population. Nat Genet 2008, 40: 1386-1387.
17. Wang L, Fan C, Topol SE, et al.: Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003, 302: 1578-1581.
18. Weng L, Kavaslar N, Ustaszewska A, et al.: Lack of MEF2A mutations in coronary artery disease. J Clin Invest 2005, 115: 1016-1020.
19. Han Y, Yang Y, Zhang X, et al.: Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population. Clin Chem Lab Med 2007, 45: 987-992.
20. Topol EJ, McCarthy J, Gabriel S, et al.: Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001, 104: 2641-2644.
21. Zhou X, Huang J, Chen J, et al.: Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population. Clin Sci (Lond) 2004, 106: 495-500.
22. Yamada Y, Izawa H, Ichihara S, et al.: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347: 1916-1923.
23. Listi F, Candore G, Lio D, et al.: Association between C1019T polymorphism of connexin37 and acute myocardial infarction: A study in patients from Sicily. Int J Cardiol 2005, 102: 269-271.
24. Wong CW, Christen T, Pfenniger A, et al.: Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction ? Atherosclerosis 2007, 191: 355-361.
25. Eriksson P, Kallin B, van't Hooft FM, et al.: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 1995, 92: 1851-1855.
26. McGlinchey PG, Spence MS, Patterson CC, et al.: The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: Anal ysis employing a family based approach. Dis Markers 2004, 20: 289-294.
27. Shiffman D, Rowland CM, Louie JZ, et al.: Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction. Arterioscler Thromb Vasc Biol 2006, 26: 1613-1618.
28. Shiffman D, O'Meara ES, Bare LA, et al.: Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2008, 28: 173-179.
29. Ye Z, Liu EH, Higgins JP, et al.: Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006, 367: 651-658.
30. Wang L, Hauser ER, Shah SH, et al.: Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet 2007, 80: 650-663.
31. Iakoubova OA, Tong CH, Rowland CM, et al.: Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: The CARE and WOSCOPS trials. J Am Coll Cardiol 2008, 51: 435-443.
32. Shiffman D, Chasman DI, Zee RY, et al.: A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. J Am Coll Cardiol 2008, 51: 444-448.
33. Iakoubova OA, Sabatine MS, Rowland CM, et al.: Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: Results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol 2008, 51: 449-455.
34. McPherson R, Pertsemlidis A, Kavaslar N, et al.: A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316: 1488-1491.
35. Samani NJ, Erdmann J, Hall AS, et al.: Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357: 443-453.
36. Helgadottir A, Thorleifsson G, Manolescu A, et al.: A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316: 1491-1493.
37. Hinohara K, Nakajima T, Takahashi M, et al.: Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 2008, 53: 357-359.
38. Shen GQ, Rao S, Martinelli N, et al.: Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet 2008, 53: 144-150.
39. Helgadottir A, Thorleifsson G, Magnusson KP, et al.: The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008, 40: 217-224.
40. Schunkert H, Gotz A, Braund P, et al.: Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008, 117: 1675-1684.
41. Talmud PJ, Cooper JA, Palmen J, et al.: Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008, 54: 467-474.
42. Roberts R: Genetics of premature myocardial infarction. Curr Atheroscler Rep 2008, 10: 186-193.